Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy

Basit Öğe Kaydı
dc.authoridBüyükavcı, Raikan Soydemir/0000-0002-2234-7158
dc.authoridBuyukavci, Mehmet Akif/0000-0001-6884-1832;
dc.authorwosidBüyükavcı, Raikan Soydemir/Q-5336-2018
dc.authorwosidBuyukavci, Mehmet Akif/HCH-2615-2022
dc.authorwosidKehoe, Clare/ABC-7984-2020
dc.contributor.authorBuyukavci, Raikan
dc.contributor.authorBuyukavci, Mehmet Akif
dc.date.accessioned2024-08-04T20:44:26Z
dc.date.available2024-08-04T20:44:26Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe aim of this study was to detect effects of ultrasound-guided botulinum toxin type-A (US-guided BoNT-A) injections prepared according to lower extremity innervation zones on spasticity and motor function in 3-16 years children with diplegic and hemiplegic spastic cerebral palsy. This study included 25 patients between 3 and 16 years of age who admitted to our clinic in 2017, were being followed in our clinic with a diagnosis of cerebral palsy, had BoNT-A injections due to lower extremity spasticity. The US-guided BoNT-A injections were administered into the spastic muscles using a specific approach according to innervation zones of muscle. Modified Ashworth Scale (MAS) and Gross Motor Functional Classification System (GMFCS) were assessed at the baseline, and 4 and 12 weeks after the BoNT-A injections. Minimum and maximum ages of the patients were 45 and 192 months, and gender distribution was 8 females and 17 males. Significant decreases in the MAS scores of the knee and ankle tones were measured 4 and 12 weeks after the BoNT-A injection when compared to the baseline scores (p < 0.025). Hip muscle tonus only decreased 12 weeks after the injection (p < 0.025). In parallel with a reduction in spasticity GMFCS improved from 3 to 2 in the 4th and 12th weeks. US-guided BoNT-A injections with Euro-musculus approach is a practical and effective method to perform injections into proper points of proper muscles in children with spastic cerebral palsy.en_US
dc.identifier.doi10.1007/s13760-018-0929-5
dc.identifier.endpage433en_US
dc.identifier.issn0300-9009
dc.identifier.issn2240-2993
dc.identifier.issue3en_US
dc.identifier.pmid29694645en_US
dc.identifier.scopus2-s2.0-85045957190en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage429en_US
dc.identifier.urihttps://doi.org/10.1007/s13760-018-0929-5
dc.identifier.urihttps://hdl.handle.net/11616/98252
dc.identifier.volume118en_US
dc.identifier.wosWOS:000442249600012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofActa Neurologica Belgicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLower limb spasticityen_US
dc.subjectUltrasound-guided botulinum toxin injectionen_US
dc.subjectInnervation zonesen_US
dc.subjectCerebral palsyen_US
dc.titleEffects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu